Filippo Pietrantonio

91PUBLICATIONS
523CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunogenetics (incl. genetic immunology)Women's studies (incl. girls' studies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (91)

|Oct 23, 2026
Prognostic Modeling Integrating RAS and SMAD4 Status in Patients with BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer.

|Sep 15, 2026
Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial.

|Jul 24, 2026
Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy.

|Apr 25, 2026
Spatial predictors of response to chemo-immunotherapy in microsatellite stable metastatic colorectal cancer.

|Apr 21, 2026
Molecular Lineages of Sporadic Mismatch Repair-Deficient Colorectal Cancer.

|Apr 21, 2026
Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

Pageof 16

Frequent Collaborators

39 joint publications

Sara Lonardi

29 joint publications

Chiara Cremolini

16 joint publications

Federica Morano

15 joint publications

Paolo Manca